Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2019

1.1 Inborn Gene or Chromosome Alterations Overview

2.1 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
2.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
2.3 Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
2.4 Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
2.5 Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

3.1 Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
3.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 8: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Molecular Diagnostic Test - Bipolar Disorder - Product Status
Table 10: Molecular Diagnostic Test - Bipolar Disorder - Product Description
Table 11: Molecular Diagnostic Test - Depression - Product Status
Table 12: Molecular Diagnostic Test - Depression - Product Description
Table 13: Molecular Diagnostic Test - Parkinson's Disease - Product Status
Table 14: Molecular Diagnostic Test - Parkinson's Disease - Product Description
Table 15: Molecular Diagnostic Test - Schizophrenia - Product Status
Table 16: Molecular Diagnostic Test - Schizophrenia - Product Description
Table 17: Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Diagnostic Test - Type 2 Diabetes - Product Status
Table 19: Diagnostic Test - Type 2 Diabetes - Product Description
Table 20: Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Status
Table 22: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Description
Table 23: Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Sensigene Trisomy 21 Laboratory Developed Test - Product Status
Table 25: Sensigene Trisomy 21 Laboratory Developed Test - Product Description
Table 26: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: SmartPanel - Product Status
Table 28: SmartPanel - Product Description
Table 29: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Diagnostic Test - IFN-Beta Resistance - Product Status
Table 31: Diagnostic Test - IFN-Beta Resistance - Product Description
Table 32: Amity University Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Prenatal Screening Kit - Product Status
Table 34: Prenatal Screening Kit - Product Description
Table 35: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 36: PDx Pre-Symptomatic Test - Product Status
Table 37: PDx Pre-Symptomatic Test - Product Description
Table 38: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Diagnostic Test - Neurodegenerative Disorders - Product Status
Table 40: Diagnostic Test - Neurodegenerative Disorders - Product Description
Table 41: Signature CF Expand - Product Status
Table 42: Signature CF Expand - Product Description
Table 43: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: SUMO Gene Test - Type 1 Diabetes - Product Status
Table 45: SUMO Gene Test - Type 1 Diabetes - Product Description
Table 46: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status
Table 48: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description
Table 49: DNA Guided Diagnostic Test - Diabetes - Product Status
Table 50: DNA Guided Diagnostic Test - Diabetes - Product Description
Table 51: DNA Guided Diagnostic Test - Obesity - Product Status
Table 52: DNA Guided Diagnostic Test - Obesity - Product Description
Table 53: INFINITI Factor II-V And MTHFR Assay - Product Status
Table 54: INFINITI Factor II-V And MTHFR Assay - Product Description
Table 55: INFINITI FMF Assay - Product Status
Table 56: INFINITI FMF Assay - Product Description
Table 57: INFINITI MTHFR Assay - Product Status
Table 58: INFINITI MTHFR Assay - Product Description

Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials